| Literature DB >> 26407383 |
Hans-Christoph Diener1, Kasja Solbach2, Dagny Holle2, Charly Gaul3.
Abstract
Migraine is a common neurological disorder, characterised by severe headaches. Epidemiological studies in the USA and Europe have identified a subgroup of migraine patients with chronic migraine. Chronic migraine is defined as ≥15 headache days per month for ≥3 months, in which ≥8 days of the month meet criteria for migraine with or without aura, or respond to treatment specifically for migraine. Chronic migraine is associated with a higher burden of disease, more severe psychiatric comorbidity, greater use of healthcare resources, and higher overall costs than episodic migraine (<15 headache days per month). There is a strong need to improve diagnosis and therapeutic treatment of chronic migraine. Primary care physicians, as well as hospital-based physicians, are integral to the identification and treatment of these patients. The latest epidemiological data, as well as treatment options for chronic migraine patients, are reviewed here. © Royal College of Physicians 2015. All rights reserved.Entities:
Keywords: Chronic migraine; chronic daily headache; onabotulinumtoxinA; preventive treatment; primary care
Mesh:
Year: 2015 PMID: 26407383 PMCID: PMC4952796 DOI: 10.7861/clinmedicine.15-4-344
Source DB: PubMed Journal: Clin Med (Lond) ISSN: 1470-2118 Impact factor: 2.659